 Single-center, double-blind, double-dummy, randomized, parallel study involving 100 non-obese BMI 27 kgm2 or lower patients with type-2-diabetes investigating the effect of treatment with metformin vs. repaglinide each in combination with biphasic insulin Insulin-aspart 3070, BIAsp30 for a period of 12 months. 